In addition, while a large body of evidence suggests that toxic gain of function is a major driver of C9orf72-related ALS/FTD4, loss or reduction of C9orf72 has also been shown to exacerbate gain of function toxicity55,56. The gene discussed is C9orf72; the disease is amyotrophic lateral sclerosis.